Abstract:CA repeat analysis using fluorescence-labeled primers is useful in the prenatal diagnosis of Duchenne muscular dystrophy in the Japanese population.
“…So far, STR analysis has mainly been used for carrier and prenatal diagnosis in non-deletional DMD families as an indirect tool for linkage study (Arenas et Shiroshita and Katayama 1997;Baranzini et al, 1998). Our results, however, clearly depict the relevance of (CA)n loci for carrier analysis and prenatal diagnosis in deletional DMD families with no previous history of the disease.…”
Dinucleotide repeat polymorphism based genetic analysis is a powerful approach to gain insight into rare genetic events like germline mosaicism and de novo mutations. The loss of heterozygosity of polym orphic dinucleotide loci at "deletional hotspot" of dystrophin gene can provide direct evidence of carrier status in female relatives of affected DMD patients with overlapped exonic deletions. We have used 4 STR loci of the central deletional hotspot of the dystrophin gene for genetic analysis in sporadic unrelated DMD families. Twenty-nine mothers of sporadic deletional cases were analysed and their carrier status was determined. Eighteen of them showed heterozygosity in the deleted loci suggesting the occurrence of de novo mutations. In 9 cases, the carrier status was indeterminate while 2 showed germline mosaicism. Our observations reiterated the importance of STR analysis in determining the status of mothers of sporadic deletional DMD cases in order to provide proper genetic counselling.
“…So far, STR analysis has mainly been used for carrier and prenatal diagnosis in non-deletional DMD families as an indirect tool for linkage study (Arenas et Shiroshita and Katayama 1997;Baranzini et al, 1998). Our results, however, clearly depict the relevance of (CA)n loci for carrier analysis and prenatal diagnosis in deletional DMD families with no previous history of the disease.…”
Dinucleotide repeat polymorphism based genetic analysis is a powerful approach to gain insight into rare genetic events like germline mosaicism and de novo mutations. The loss of heterozygosity of polym orphic dinucleotide loci at "deletional hotspot" of dystrophin gene can provide direct evidence of carrier status in female relatives of affected DMD patients with overlapped exonic deletions. We have used 4 STR loci of the central deletional hotspot of the dystrophin gene for genetic analysis in sporadic unrelated DMD families. Twenty-nine mothers of sporadic deletional cases were analysed and their carrier status was determined. Eighteen of them showed heterozygosity in the deleted loci suggesting the occurrence of de novo mutations. In 9 cases, the carrier status was indeterminate while 2 showed germline mosaicism. Our observations reiterated the importance of STR analysis in determining the status of mothers of sporadic deletional DMD cases in order to provide proper genetic counselling.
“…Linkage analysis based on dinucleotide (CA)n polymorphic loci in the dystrophin gene has been widely used in the carrier analysis and prenatal diagnosis of D/BMD families where no intragenic deletion(s) has been detected in the proband [7–9]. We have evaluated the utility of (CA)n linkage analysis in the determination of carrier status in deletional DMD families having intragenic deletion in the major hotspot (exons 44–52) region.…”
Section: Carrier Status Of Mothers and Female Siblings In Deletional mentioning
“…Several methods have been devised to identify deletions, duplications, and point mutations in affected males and female carriers 6–10. Segregation analysis of short tandem repeat (STR) polymorphic loci in the dystrophin gene is widely used for carrier detection and prenatal diagnosis of DMD/BMD families, in which the causative mutations cannot be identified in either the proband or female 11–14…”
Overall, 19 of 24 (79%) molecular prenatal diagnoses were informative, indicating that multiplex PCR/STR segregation analysis is a reliable method for carrier detection and prenatal diagnosis when other more sophisticated techniques are unavailable.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.